Synfini Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $8.9M

  • Investors
  • 12

Synfini General Information

Description

Developer of an artificial intelligence (AI) drug discovery platform designed to accelerate chemistry design, development, and synthesis. The company's platform is powered by integrated neuro-symbolic, robotic automation and extensive chemistry data, and also utilizes streamlined hit discovery with custom target-specific models and advanced models for molecular optimization, enabling scientists to create novel therapeutics.

Contact Information

Website
www.synfini.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Menlo Park, CA
  • United States
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Menlo Park, CA
  • United States

Synfini Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synfini Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 07-Jul-2025 $8.9M Completed Generating Revenue
4. Early Stage VC 01-Jan-2025 Completed Generating Revenue
3. Seed Round 26-Sep-2023 Completed Generating Revenue
2. Grant 26-Sep-2023 $40M Completed Generating Revenue
1. Spin-Off 26-Sep-2023 Completed Generating Revenue
To view Synfini’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Synfini Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synfini Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ferocity Capital Venture Capital Minority
Foothill Ventures Venture Capital Minority
Gaingels Venture Capital Minority
Global Innovation Labs (California) Venture Capital Minority
High Water Venture Partners Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Synfini FAQs

  • When was Synfini founded?

    Synfini was founded in 2023.

  • Where is Synfini headquartered?

    Synfini is headquartered in Menlo Park, CA.

  • What is the size of Synfini?

    Synfini has 5 total employees.

  • What industry is Synfini in?

    Synfini’s primary industry is Drug Discovery.

  • Is Synfini a private or public company?

    Synfini is a Private company.

  • What is Synfini’s current revenue?

    The current revenue for Synfini is .

  • How much funding has Synfini raised over time?

    Synfini has raised $13M.

  • Who are Synfini’s investors?

    Ferocity Capital, Foothill Ventures, Gaingels, Global Innovation Labs (California), and High Water Venture Partners are 5 of 12 investors who have invested in Synfini.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process